Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln
November 19, 2014 at 08:07 AM EST
Nov 19 (Reuters) - Pharmaceutical investment firm Royalty Pharma said it would buy royalties on Vertex Pharmaceuticals Inc's cystic fibrosis treatments from Cystic Fibrosis Foundation for $3.3 billion in cash.